Patent · US Expired

Compounds

US7528156B2 · kind B2 · utility

1Cited by

28References

23Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Tomas Eriksson · Kvicksund, SE
Tomas Klingstedt · Lund, SE
Tesfaledet Mussie · Lund, SE

Key dates

Filing date	Nov 22, 2004
Grant date	May 5, 2009
Priority date	—
Expiry date	Apr 15, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of general formula (D wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.